Literature DB >> 12491197

Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis.

Ramakrishna Vankayalapati1, Benjamin Wizel, Stephen E Weis, Peter Klucar, Homayoun Shams, Buka Samten, Peter F Barnes.   

Abstract

We measured serum cytokine concentrations and Mycobacterium tuberculosis-stimulated cytokine production by peripheral blood mononuclear cells (PBMCs) obtained from persons infected with M. tuberculosis. Serum interferon-gamma (IFN-gamma) and interleukin-10 (IL-10) concentrations were elevated in patients with tuberculosis compared with healthy persons who had reactions to tuberculin skin tests, but IL-18 concentrations were not. In contrast, M. tuberculosis-stimulated PBMCs from patients with tuberculosis produced less IFN-gamma and IL-18 but similar amounts of IL-10, compared with PBMCs from healthy subjects who had reactions to tuberculin skin tests. Pretreatment of PBMCs from healthy subjects with reaction to tuberculin with serum from patients with tuberculosis inhibited IFN-gamma production in response to M. tuberculosis, and inhibition was blocked by anti-IL-10. Thus, serum concentrations of IFN-gamma, IL-18, and IL-10 do not parallel M. tuberculosis-induced cytokine levels, and increased IL-10 serum levels in patients with tuberculosis inhibit IFN-gamma production in response to mycobacterial antigens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12491197     DOI: 10.1086/344903

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

1.  Endogenously activated interleukin-4 differentiates disease progressors and non-progressors in tuberculosis susceptible families: a 2-year biomarkers follow-up study.

Authors:  Rabia Hussain; Najeeha Talat; Ambreen Ansari; Firdaus Shahid; Zahra Hasan; Ghaffar Dawood
Journal:  J Clin Immunol       Date:  2011-07-14       Impact factor: 8.317

2.  Detection of in vitro interferon-gamma and serum tumour necrosis factor-alpha in multidrug-resistant tuberculosis patients.

Authors:  A Fortes; K Pereira; P R Z Antas; C L M C Franken; M Dalcolmo; M M Ribeiro-Carvalho; K S Cunha; A Geluk; A Kritski; A Kolk; P Klatser; E N Sarno; T H M Ottenhoff; E P Sampaio
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

3.  Effect of chemotherapy on whole-blood cytokine responses to Mycobacterium tuberculosis antigens in a small cohort of patients with pulmonary tuberculosis.

Authors:  Sylvie Bertholet; David J Horne; Elsa M Laughlin; Margery Savlov; Ines Tucakovic; Rhea N Coler; Masahiro Narita; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2011-06-29

4.  Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice.

Authors:  Noton K Dutta; Peter B Illei; Sanjay K Jain; Petros C Karakousis
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

Review 5.  [Immune response to Mycobacterium tuberculosis].

Authors:  A Nowag; P Hartmann
Journal:  Internist (Berl)       Date:  2016-02       Impact factor: 0.743

6.  Plasma Proinflammatory Cytokines Are Markers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis.

Authors:  Nathella Pavan Kumar; Kadar Moideen; Vaithilingam V Banurekha; Dina Nair; Subash Babu
Journal:  Open Forum Infect Dis       Date:  2019-05-31       Impact factor: 3.835

7.  T Cell Activation and Proinflammatory Cytokine Production in Clinically Cured Tuberculosis Are Time-Dependent and Accompanied by Upregulation of IL-10.

Authors:  Marcos Vinícius da Silva; Amanda A Figueiredo; Juliana R Machado; Lúcio C Castellano; Patricia B D Alexandre; Rafael F Oliveira; Gladstone E L Faria; Sanívia A L Pereira; Denise B R Rodrigues; Virmondes Rodrigues
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

8.  Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis.

Authors:  Zahra Hasan; Irfan Zaidi; Bushra Jamil; M Aslam Khan; Akbar Kanji; Rabia Hussain
Journal:  BMC Immunol       Date:  2005-07-07       Impact factor: 3.615

9.  IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB.

Authors:  Thorsten Thye; Edmund N Browne; Margaret A Chinbuah; John Gyapong; Ivy Osei; Ellis Owusu-Dabo; Norbert W Brattig; Stefan Niemann; Sabine Rüsch-Gerdes; Rolf D Horstmann; Christian G Meyer
Journal:  PLoS One       Date:  2009-05-01       Impact factor: 3.240

10.  Role of the interleukin 10 family of cytokines in patients with immune reconstitution inflammatory syndrome associated with HIV infection and tuberculosis.

Authors:  Rebecca Tadokera; Katalin A Wilkinson; Graeme A Meintjes; Keira H Skolimowska; Kerryn Matthews; Ronnett Seldon; Molebogeng X Rangaka; Gary Maartens; Robert J Wilkinson
Journal:  J Infect Dis       Date:  2013-01-09       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.